News

Janux Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on next-generation immunotherapies, has entered into a collaboration and exclusive worldwide license…
Read More...

China’s National Medical Products Administration (NMPA) has approved ENHERTU® (trastuzumab deruxtecan) for the treatment of adult patients with locally advanced or metastatic…
Read More...

Insilico Medicine and Hygtia Therapeutics have entered into an exclusive global license and co-development agreement to advance ISM8969, an investigational NLRP3 inhibitor designed for…
Read More...

Wugen has received a major regulatory endorsement from the U.S. Food and Drug Administration, which has granted Breakthrough Therapy Designation to its investigational CAR-T cell…
Read More...

Charles River Laboratories International and Gazi University Faculty of Medicine have entered into a strategic collaboration aimed at advancing gene therapy research for rare genetic…
Read More...

NEOK Bio has taken a key step toward clinical development after the U.S. Food and Drug Administration approved its Investigational New Drug application for NEOK001, clearing the way for…
Read More...

Opna Bio, a clinical-stage biopharmaceutical company focused on developing novel cancer therapies, has received a key regulatory boost for its myelofibrosis program. The U.S. Food and…
Read More...

Novo Nordisk and Aspect Biosystems have announced the expansion of their strategic partnership, entering a new phase focused on developing advanced cellular medicines for diabetes that…
Read More...

Bristol Myers Squibb (BMS) has entered into a strategic collaboration with Microsoft to accelerate the early detection of lung cancer by integrating advanced artificial intelligence…
Read More...

GSK plc and Japan-based pharmaceutical company Shionogi & Co., Ltd. have reached an agreement, alongside Pfizer Inc., to reshape the ownership structure of ViiV Healthcare, the…
Read More...

AstraZeneca has agreed to acquire AbelZeta Pharma’s remaining stake in the China development and commercialization rights to C-CAR031, consolidating full global control of the…
Read More...

iRegene Therapeutics has reached a major regulatory milestone with its lead program for Parkinson’s disease, as the U.S. Food and Drug Administration granted Regenerative Medicine…
Read More...

Novartis has received a significant regulatory boost for its autoimmune disease pipeline after the U.S. Food and Drug Administration granted Breakthrough Therapy designation to…
Read More...

AstraZeneca has acquired Modella AI, a life sciences–focused artificial intelligence company, in a move that deepens the companies’ existing collaboration and strengthens AstraZeneca’s…
Read More...

Agenus Inc. has completed the closing of its previously announced strategic collaboration with Zydus Lifesciences Ltd., a move aimed at accelerating the global development and potential…
Read More...

The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have jointly agreed on ten principles for good artificial intelligence (AI) practice across the…
Read More...

InterAx Biotech Ltd and Alveus Therapeutics Inc. have entered into a strategic research collaboration and licensing agreement aimed at developing a differentiated small-molecule therapy…
Read More...

Illumina has unveiled what it calls the world’s largest genome-wide genetic perturbation dataset, a major initiative designed to accelerate artificial intelligence–driven drug discovery…
Read More...

SciNeuro Pharmaceuticals has entered into a worldwide licensing and collaboration agreement with Novartis Pharma AG to advance a novel antibody program for the treatment of Alzheimer’s…
Read More...

NVIDIA and Eli Lilly and Company have announced the creation of a first-of-its-kind AI co-innovation lab designed to apply artificial intelligence to some of the most persistent…
Read More...